Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus jensenii LBV 116 and Improved Vaginal Microbiota

Research synthesisModerate evidenceMixed effect size4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 studies, all reported beneficial effects on vaginal microbiota, with the highest-quality evidence (a meta-analysis) showing a statistically significant moderate-sized reduction in Nugent score. The overall effect sizes were mixed (small to moderate). No consistent dose or form was reported across studies.

  • Studied populations: Women with vaginal dysbiosis (including bacterial vaginosis, intermediate Nugent score), postmenopausal breast cancer patients on chemotherapy, pregnant women with herpes, and male-to-female transsexual women.

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. Additionally, the studies used mixed Lactobacillus strains rather than specifically L. jensenii LBV 116; direct evidence for this specific strain is lacking.

Generated May 12, 2026
4 of 4 papers
Back to top